Dependence of ABCB1 transporter expression and function on distinct sphingolipids generated by ceramide synthases-2 and -6 in chemoresistant renal cancer

Autor: Wing-Kee Lee, Michelle Maaß, Amy Quach, Nataliya Poscic, Holly Prangley, Erin-Claire Pallott, Jiyoon L. Kim, Jason S. Pierce, Besim Ogretmen, Anthony H. Futerman, Frank Thévenod
Jazyk: angličtina
Rok vydání: 2021
Předmět:
TG
thapsigargin

Male
cancer drug resistance
FASN
fatty acid synthase

Biochemistry
ERAD
ER-associated degradation

UPR
unfolded protein response

MDR
multidrug resistance

Tandem Mass Spectrometry
Sphingosine N-Acyltransferase
Tumor Microenvironment
HERPUD1
homocysteine-inducible ER protein with ubiquitin-like domain 1

GRP78
glucose-regulated protein 78 kDa

unfolded protein response
Endoplasmic Reticulum-Associated Degradation
Kidney Neoplasms
XBP1
X-box binding protein 1

lipids (amino acids
peptides
and proteins)

Female
ABC transporter
ATP6α
activating transcription factor 6α

Research Article
ATP Binding Cassette Transporter
Subfamily B

PDIA4
protein disulfide isomerase family A member 4

P-glycoprotein
CHOP
C/EBP homologous protein

Ceramides
ACACA
acetyl-CoA carboxylase alpha

ER
endoplasmic reticulum

VLC
very long chain

LCC
long-chain ceramide

HPCT
human proximal convoluted tubule

Humans
RNA
Messenger

TUN
tunicamycin

Molecular Biology
Sphingolipids
SM
sphingomyelin

UCSC
University of California
Santa Cruz

SREBP
sterol-regulatory element binding protein

LD
lipid domain

Tumor Suppressor Proteins
Membrane Proteins
Cell Biology
DOX
doxorubicin

Doxorubicin
Drug Resistance
Neoplasm

Mff
mitochondrial fission factor

CerS
ceramide synthase

HMGCL
3-hydroxymethyl-3-methylglutaryl-CoA lyase

TM
transmembrane
Zdroj: The Journal of Biological Chemistry
ISSN: 1083-351X
0021-9258
Popis: Oncogenic multidrug resistance (MDR) is commonly intrinsic to renal cancer based on the physiological expression of detoxification transporters, particularly ABCB1, thus hampering chemotherapy. ABCB1 activity is directly dependent on its lipid microenvironment, localizing to cholesterol- and sphingomyelin-rich domains. As ceramides are the sole source for sphingomyelins, we hypothesized that ceramide synthase (CerS)-derived ceramides regulate ABCB1 activity. Using data from RNA-seq databases, we found patient kidney tumors exhibited increased CerS2 mRNA, which was inversely correlated with CerS6 mRNA in ABCB1+ clear cell carcinomas. Endogenous elevated CerS2 and lower CerS5/6 mRNA and protein resulted in disproportionately higher CerS2 to CerS5/6 activities (2-fold) in chemoresistant ABCB1high (A498, Caki-1) compared to chemosensitive ABCB1low (ACHN, HPCT) cells. In addition, lipidomics analyses by HPLC-MS/MS showed bias towards CerS2-associated C20:0/C20:1-ceramides compared to CerS5/6-associated C14:0/C16:0-ceramides (2:1). Sphingomyelins were similarly altered. We demonstrated that chemoresistance to doxorubicin in ABCB1high cells was partially reversed by inhibitors of de novo ceramide synthesis (L-cycloserine) and CerS (fumonisin B1) in cell viability assays. Additionally, downregulation of CerS2/6, but not CerS5, attenuated ABCB1 mRNA, protein, plasma membrane localization, rhodamine 123+ efflux transport activity, and doxorubicin resistance. Similar findings were observed with catalytically-inactive CerS6-H212A. Furthermore, CerS6-targeting siRNA shifted ceramide and sphingomyelin composition to ultra long-chain species (C22-C26). Inhibitors of ER-associated degradation (ERAD) (eeyarestatin I) and the proteasome (MG132, bortezomib) prevented ABCB1 loss induced by CerS2/6 downregulation. We conclude that a critical balance in ceramide/sphingomyelin species is prerequisite to ABCB1 expression and functionalization, which could be targeted to reverse MDR in renal cancers. Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.
Databáze: OpenAIRE